Clinical Trials Directory

Trials / Unknown

UnknownNCT02060773

Effect of EGDT on Hepatic Perfusion in Patients With Septic Shock

Status
Unknown
Phase
Study type
Observational
Enrollment
Sponsor
Zhongda Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

To observe the effect of early goal directed therapy (EGDT) on hepatic perfusion in patients with septic shock. Hypothesis: Hepatic perfusion did not improved after EGDT in patients with septic shock.

Detailed description

Objective To observe the effect of early goal directed therapy (EGDT) on hepatic perfusion in patients with septic shock. Methods A prospective observational study was carried out. The eligible patients were treated with the standard procedure of EGDT. The hemodynamic data were recorded. Oxygen metabolism and hepatic function were monitored. Indocyanine clearance test was applied to detect the hepatic perfusion. Hemodynamics, hepatic perfusion, oxygen metabolism and hepatic function were compared before treatment, after EGDT and 24 hours after EGDT.

Conditions

Timeline

Start date
2012-12-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2014-02-12
Last updated
2014-02-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02060773. Inclusion in this directory is not an endorsement.

Effect of EGDT on Hepatic Perfusion in Patients With Septic Shock (NCT02060773) · Clinical Trials Directory